Profiel
Jonathan D.
Alspaugh is President & Chief Strategy Officer at Rycarma Therapeutics, Inc. since 2024.
Formerly, Mr. Alspaugh was President, CEO, CFO & Chief Accounting Officer at Spyre Therapeutics, Inc. in 2023.
From 2013 to 2021, Mr. Alspaugh was Managing Director at Evercore, Inc. Education includes undergraduate and graduate degrees from the University of Michigan and an MBA from MIT Sloan School of Management.
Actieve functies van Jonathan Alspaugh
| Bedrijven | Functie | Begin |
|---|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | President | 07-01-2024 |
Eerdere bekende functies van Jonathan Alspaugh
| Bedrijven | Functie | Einde |
|---|---|---|
| EVERCORE INC. | Algemeen Directeur | 01-06-2021 |
| SPYRE THERAPEUTICS, INC. | Algemeen Directeur | - |
Opleiding van Jonathan Alspaugh
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Evercore, Inc.
Evercore, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















